Nones et al. demonstrated that 21 breast cancers from 22 BRCA2 pathogenic variant carriers (95%) in their study exhibited reduced BRCA function, whereas only one was BRCA-proficient48. The gene discussed is BRCA2; the disease is breast cancer.